Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine

Published:2016-06-10 Issue:1 Volume:14 Page:
ISSN:1477-3155
Container-title:Journal of Nanobiotechnology
language:en
Short-container-title:J Nanobiotechnol

Author:

Rioux Gervais,Carignan Damien,Russell Alexis,Bolduc Marilène,Gagné Marie-Ève Laliberté,Savard Pierre,Leclerc Denis^ORCID

Funder

Canadian Institutes of Health Research

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Link

http://link.springer.com/content/pdf/10.1186/s12951-016-0200-2

Reference36 articles.

1. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:36–44.

2. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2006;24:1159–69.

3. Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. CurrOpin Immunol. 2014;29:38–42.

4. Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med. 2013;19:1597–608.

5. O’Hagan DT, De Gregorio E. The path to a successful vaccine adjuvant—”the long and winding road.”. Drug Discov Today. 2009;14:541–51.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection;Nanomedicine: Nanotechnology, Biology and Medicine;2022-08

2. Alfalfa mosaic virus nanoparticles-based in situ vaccination induces antitumor immune responses in breast cancer model;Nanomedicine;2021-01

3. A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age;Vaccines;2020-07-20

4. Advances and Challenges of Nanoparticle-Based Macrophage Reprogramming for Cancer Immunotherapy;Biochemistry (Moscow);2019-07

5. Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine Platform;Vaccines;2019-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3